Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine welcomed the State of Florida’s Chief Financial Officer, Jimmy Patronis, on February 5, giving him a tour of its cancer-fighting technologies. Patronis also met with representatives from more than a dozen of South Florida’s fire departments whose members are collaborating with Sylvester’s Firefighters Cancer Initiative.
Felicia Marie Knaul, Ph.D., a member of Sylvester Comprehensive Cancer Center, professor of public health sciences and director of the University of Miami Institute for Advanced Study of the Americas, described the challenges of global women’s cancer disparities in a grand rounds presentation Jan. 31, part of a lecture series presented by Sylvester’s Global Oncology and International Programs.
New findings by researchers at Sylvester Comprehensive Cancer Center may prove to be an important solution to one of the more difficult problems faced in the field of precision medicine when it comes to treating cancer. An article reporting their findings, “Discordancy Partitioning for Validating Potentially Inconsistent Pharmacogenomic Studies,” was published online November 9 by Scientific Reports.
Sylvester Researchers and Colleagues Identify Novel Therapeutic Target for Incurable Prostate Cancer
A collaborative study by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and colleagues has identified a novel therapeutic target for incurable prostate cancer. The research found a critical role for thioredoxin-1, a protein that protects cells from oxidative stress, in the progression of prostate cancer to the incurable castration-resistant stage.
An international collaboration among researchers in Miami, New York, and Montreal aims to determine the best strategies for effectively providing people who inject drugs with pre-exposure prophylaxis (PrEP) to protect them from HIV infection. Their efforts will be backed by an $8 million grant just awarded from the National Institute on Drug Abuse.